Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Retinitis Pigmentosa
Biotech
Nanoscope's gene therapy boosts vision function in phase 2 test
Nanoscope has scored a phase 2 win for its gene therapy using light-sensitive molecules to treat retinal disease.
James Waldron
Mar 30, 2023 11:04am
J&J links gene therapy to improved vision in early-phase trial
Oct 3, 2022 8:00am
Drug for alcoholics might be the key to vision treatment
Mar 18, 2022 2:08pm
Second Sight slashes support for 'bionic eyes': report
Feb 17, 2022 11:48am
Biogen joins Harvard in gene therapy pact to fight eye disease
Jul 6, 2020 10:55am
Biogen bails on AGTC after ocular gene therapy flunks trial
Dec 13, 2018 9:32am